Compare EPAC & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EPAC | INSP |
|---|---|---|
| Founded | 1910 | 2007 |
| Country | United States | United States |
| Employees | 2100 | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.6B |
| IPO Year | 1994 | 2018 |
| Metric | EPAC | INSP |
|---|---|---|
| Price | $34.14 | $41.71 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 16 |
| Target Price | $48.00 | ★ $94.00 |
| AVG Volume (30 Days) | 329.5K | ★ 1.0M |
| Earning Date | 03-25-2026 | 05-04-2026 |
| Dividend Yield | ★ 0.12% | N/A |
| EPS Growth | 8.97 | ★ 179.43 |
| EPS | ★ 0.67 | N/A |
| Revenue | ★ $616,899,000.00 | $82,050,000.00 |
| Revenue This Year | $5.60 | $8.02 |
| Revenue Next Year | $5.56 | $8.11 |
| P/E Ratio | $51.36 | ★ N/A |
| Revenue Growth | 4.65 | ★ 62.18 |
| 52 Week Low | $33.66 | $42.84 |
| 52 Week High | $45.42 | $152.36 |
| Indicator | EPAC | INSP |
|---|---|---|
| Relative Strength Index (RSI) | 39.26 | 28.19 |
| Support Level | N/A | N/A |
| Resistance Level | $36.56 | $59.40 |
| Average True Range (ATR) | 0.90 | 2.59 |
| MACD | -0.02 | -1.16 |
| Stochastic Oscillator | 9.35 | 0.58 |
Enerpac Tool Group Corp provides high-precision hydraulic and mechanical tools, controlled-force products, and heavy lifting solutions. Operating mainly through its Industrial Tools & Services (IT&S) segment, the company designs, manufactures, and distributes branded tools, and offers maintenance, bolting, machining, joint integrity, and equipment rental services across industries such as oil & gas, manufacturing, power generation, and infrastructure. Its key products include hydraulic cylinders, pumps, torque wrenches, and bolt tensioners under the brands ENERPAC and HYDRATIGHT. The company serves customers internationally, with operations in the USA, Australia, Brazil, Germany, Saudi Arabia, the United Kingdom, and other countries, deriving the majority of its revenue from the USA.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.